Who Buys Acarbose from India — 82 Importers Behind a $6.8M Market

The importation of Acarbose from India involves various buyer segments, each with distinct purchasing behaviors:

• Distributors: Entities like STRIDES PHARMA INC (United States) and MARCAN PHARMACEUTICALS INC. (Canada) function as intermediaries, procuring Acarbose in bulk to supply to pharmacies, hospitals, and healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.

• Hospital Groups: Organizations such as MICRO MEGA LANKA (PRIVATE) LIMITED (Sri Lanka) import Acarbose directly for use within their healthcare facilities. Their procurement is typically based on patient demand and formulary requirements, leading to consistent, moderate-sized orders.

• Retail Chains: While not explicitly listed among the top buyers, retail pharmacy chains may also import Acarbose to stock their outlets, ensuring availability for consumers. Their purchasing behavior often involves smaller, more frequent orders aligned with consumer demand.

• Government Procurement: Entities like INDIES PHARMA JAMAICA LIMITED (Jamaica) may engage in government tenders to supply Acarbose for public health programs. These purchases are typically large-scale and periodic, aligning with budget cycles and public health initiatives.

• Re-exporters: Companies such as ARROW GENERIQUES (France) might import Acarbose not only for domestic distribution but also for re-export to other markets, leveraging their distribution networks. Their order sizes and frequencies can vary based on international demand.

• Contract Manufacturers: Some buyers may act as contract manufacturers, importing Acarbose as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement patterns depend on production schedules and contractual obligations.

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process for Acarbose: Importers must ensure that Acarbose is FDA-approved. This involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions.

3. Estimated Timeline for Registration: The FDA review process typically takes 10 months for standard applications, though priority reviews can be expedited to 6 months.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.

Canada

1. Drug Regulatory Authority: Health Canada.

2. Import Registration Process for Acarbose: Importers must obtain a Drug Identification Number (DIN) by submitting a New Drug Submission (NDS) or an Abbreviated New Drug Submission (ANDS) for generics.

3. Estimated Timeline for Registration: The review process can take 300 days for standard NDS and 180 days for priority reviews.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically duty-free in Canada.

Sri Lanka

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process for Acarbose: Importers must register the product with the NMRA by submitting a dossier that includes quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the submission.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally exempt from import duties in Sri Lanka.

France

1. Drug Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).

2. Import Registration Process for Acarbose: Importers must obtain a Marketing Authorization (MA) by submitting a dossier to the ANSM, which includes clinical data and manufacturing information.

3. Estimated Timeline for Registration: The standard review process takes about 210 days, though it can be extended if additional information is required.

4. Import Tariff/Duty for HS 30049099: Under the European Union's Common External Tariff, pharmaceuticals under this HS code are typically duty-free.

Jamaica

1. Drug Regulatory Authority: Pharmacy Council of Jamaica.

2. Import Registration Process for Acarbose: Importers must register the drug with the Pharmacy Council by providing documentation on the product's quality, safety, and efficacy.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 9 months.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally subject to a 5% import duty in Jamaica.

The demand for Acarbose in importing countries is primarily driven by the increasing prevalence of type 2 diabetes mellitus (T2DM). According to the World Health Organization (WHO), diabetes is a major public health concern, with rising incidence rates globally. In response, many countries have implemented government healthcare programs aimed at managing and treating diabetes, thereby increasing the demand for antidiabetic medications like Acarbose.

Additionally, the inclusion of antidiabetic treatments in the WHO Model List of Essential Medicines underscores the importance of these drugs in managing diabetes. This inclusion often influences national procurement strategies, leading to tender-based purchasing and integration into universal health coverage schemes. The presence of 82 buyers across 37 countries, as per our data, indicates a broad and growing market opportunity for Acarbose, reflecting its critical role in global diabetes management efforts.

The importation of Acarbose from India involves various buyer segments, each with distinct purchasing behaviors:

• Distributors: Entities like STRIDES PHARMA INC (United States) and MARCAN PHARMACEUTICALS INC. (Canada) function as intermediaries, procuring Acarbose in bulk to supply to pharmacies, hospitals, and healthcare providers. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.

• Hospital Groups: Organizations such as MICRO MEGA LANKA (PRIVATE) LIMITED (Sri Lanka) import Acarbose directly for use within their healthcare facilities. Their procurement is typically based on patient demand and formulary requirements, leading to consistent, moderate-sized orders.

• Retail Chains: While not explicitly listed among the top buyers, retail pharmacy chains may also import Acarbose to stock their outlets, ensuring availability for consumers. Their purchasing behavior often involves smaller, more frequent orders aligned with consumer demand.

• Government Procurement: Entities like INDIES PHARMA JAMAICA LIMITED (Jamaica) may engage in government tenders to supply Acarbose for public health programs. These purchases are typically large-scale and periodic, aligning with budget cycles and public health initiatives.

• Re-exporters: Companies such as ARROW GENERIQUES (France) might import Acarbose not only for domestic distribution but also for re-export to other markets, leveraging their distribution networks. Their order sizes and frequencies can vary based on international demand.

• Contract Manufacturers: Some buyers may act as contract manufacturers, importing Acarbose as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement patterns depend on production schedules and contractual obligations.

Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.

United States

1. Drug Regulatory Authority: U.S. Food and Drug Administration (FDA).

2. Import Registration Process for Acarbose: Importers must ensure that Acarbose is FDA-approved. This involves submitting a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) for generic versions.

3. Estimated Timeline for Registration: The FDA review process typically takes 10 months for standard applications, though priority reviews can be expedited to 6 months.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under HS code 30049099 are generally duty-free in the United States.

Canada

1. Drug Regulatory Authority: Health Canada.

2. Import Registration Process for Acarbose: Importers must obtain a Drug Identification Number (DIN) by submitting a New Drug Submission (NDS) or an Abbreviated New Drug Submission (ANDS) for generics.

3. Estimated Timeline for Registration: The review process can take 300 days for standard NDS and 180 days for priority reviews.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically duty-free in Canada.

Sri Lanka

1. Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

2. Import Registration Process for Acarbose: Importers must register the product with the NMRA by submitting a dossier that includes quality, safety, and efficacy data.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 12 months, depending on the completeness of the submission.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally exempt from import duties in Sri Lanka.

France

1. Drug Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).

2. Import Registration Process for Acarbose: Importers must obtain a Marketing Authorization (MA) by submitting a dossier to the ANSM, which includes clinical data and manufacturing information.

3. Estimated Timeline for Registration: The standard review process takes about 210 days, though it can be extended if additional information is required.

4. Import Tariff/Duty for HS 30049099: Under the European Union's Common External Tariff, pharmaceuticals under this HS code are typically duty-free.

Jamaica

1. Drug Regulatory Authority: Pharmacy Council of Jamaica.

2. Import Registration Process for Acarbose: Importers must register the drug with the Pharmacy Council by providing documentation on the product's quality, safety, and efficacy.

3. Estimated Timeline for Registration: The registration process can take approximately 6 to 9 months.

4. Import Tariff/Duty for HS 30049099: Pharmaceuticals under this HS code are generally subject to a 5% import duty in Jamaica.

The demand for Acarbose in importing countries is primarily driven by the increasing prevalence of type 2 diabetes mellitus (T2DM). According to the World Health Organization (WHO), diabetes is a major public health concern, with rising incidence rates globally. In response, many countries have implemented government healthcare programs aimed at managing and treating diabetes, thereby increasing the demand for antidiabetic medications like Acarbose.

Additionally, the inclusion of antidiabetic treatments in the WHO Model List of Essential Medicines underscores the importance of these drugs in managing diabetes. This inclusion often influences national procurement strategies, leading to tender-based purchasing and integration into universal health coverage schemes. The presence of 82 buyers across 37 countries, as per our data, indicates a broad and growing market opportunity for Acarbose, reflecting its critical role in global diabetes management efforts.